Subsequently, an array of experimental techniques, including RNA sequencing, were employed to examine the impact of DBF4 on HCC progression and elucidate the molecular pathways through which DBF4 drives HCC advancement. This evidence concerns the gene DBF4 and hepatocellular carcinoma.